-
Exploring oxidative phosphorylation as therapeutic vulnerability in high risk acute myeloid leukemia
Read MoreThe standard of care for AML patients was introduced in the 1970s and has not significantly changed since then. Patients suffering from…
-
Florian Kuchenbauer
Primary Investigator
-
